Abstract
The staphylococci are an ever-present threat in our world, capable of causing a wide range of infections, and are a persistent presence in the clinical environment. As the number of antimicrobial compounds effective against staphylococci decreases, because of the acquisition and spread of antibiotic resistance, there is a growing need for novel therapeutic molecules. Intra and inter-species communication (quorum sensing) is a biologically significant phenomenon that has been associated with virulence, intracellular survival, and biofilm formation. Quorum sensing molecules of staphylococci and other species (e.g. Pseudomonas aeruginosa) can inhibit virulence factor production and/or growth of staphylococci, leading to the possibility that interference with staphylococcal quorum-sensing systems could be a way of controlling the diverse infections caused by the staphylococci. In this article, we discuss the potential of quorum-sensing systems of staphylococci as therapeutic targets.
Similar content being viewed by others
References
Wisplinghoff H, Seifert H, Tallent SM, Bischoff T, Wenzel RP, Edmond MB (2003) Pediatr Infect Dis J 22:686–691
Karlowsky JA, Jones ME, Draghi DC, Thornsberry C, Sahm DF, Volturo GA (2004) Ann Clin Microbiol Antimicrob 3:7
Lowy FD (1998) N Engl J Med 339:520–532
Vuong C, Otto M (2002) Microbes Infect 4:481–489
Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J (2003) Emerg Infect Dis 9:978–984
Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S (1993) EMBO J 12:3967–3975
Saravia-Otten P, Muller HP, Arvidson S (1997) J Bacteriol 179:5259–5263
Novick RP (2003) Mol Microbiol 48:1429–1449
Dunman PM, Murphy E, Haney S, Palacios D, Tucker-Kellogg G, Wu S, Brown EL, Zagursky RJ, Shlaes D, Projan SJ (2001) J Bacteriol 183:7341–7353
Qazi SN, Counil E, Morrissey J, Rees CE, Cockayne A, Winzer K, Chan WC, Williams P, Hill PJ (2001) Infect Immun 69:7074–7082
Cheung AL, Eberhardt KJ, Chung E, Yeaman MR, Sullam PM, Ramos M, Bayer AS (1994) J Clin Invest 94:1815–1822
Cheung AL, Bayer AS, Zhang G, Gresham H, Xiong YQ (2004) FEMS Immunol Med Microbiol 40:1–9
Wright JS III, Jin R, Novick RP (2005) Proc Natl Acad Sci USA 102:1691–1696
Traber K, Novick R (2006) Mol Microbiol 59:1519–1530
Yao Y, Sturdevant DE, Villaruz A, Xu L, Gao Q, Otto M (2005) Infect Immun 73:1856–1860
Dufour P, Jarraud S, Vandenesch F, Greenland T, Novick RP, Bes M, Etienne J, Lina G (2002) J Bacteriol 184:1180–1186
Vandenesch F, Projan SJ, Kreiswirth B, Etienne J, Novick RP (1993) FEMS Microbiol Lett 111:115–122
Ji G, Pei W, Zhang L, Qiu R, Lin J, Benito Y, Lina G, Novick RP (2005) J Bacteriol 187:3139–3150
Sung JM, Chantler PD, Lloyd DH (2006) Infect Immun 74:2947–2956
Sakinc T, Kulczak P, Henne K, Gatermann SG (2004) FEMS Microbiol Lett 237:157–161
Recsei P, Kreiswirth B, O’Reilly M, Schlievert P, Gruss A, Novick RP (1986) Mol Gen Genet 202:58–61
Peng HL, Novick RP, Kreiswirth B, Kornblum J, Schlievert P (1988) J Bacteriol 170:4365–4372
Janzon L, Lofdahl S, Arvidson S (1989) Mol Gen Genet 219:480–485
van Wamel WJ, van Rossum G, Verhoef J, Vandenbroucke-Grauls CM, Fluit AC (1998) FEMS Microbiol Lett 163:1–9
Otto M, Sussmuth R, Jung G, Gotz F (1998) FEBS Lett 424:89–94
Zhang L, Gray L, Novick RP, Ji G (2002) J Biol Chem 277:34736–34742
Qiu R, Pei W, Zhang L, Lin J, Ji G (2005) J Biol Chem 280:16695–16704
Ji G, Beavis R, Novick RP (1997) Science 276:2027–2030
Moore PC, Lindsay JA (2001) J Clin Microbiol 39:2760–2767
Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Vandenesch F, Piemont Y, Brousse N, Floret D, Etienne J (2002) Lancet 359:753–759
Carmody AB, Otto M (2004) Arch Microbiol 181:250–253
Sakoulas G, Eliopoulos GM, Moellering RC Jr, Wennersten C, Venkataraman L, Novick RP, Gold HS (2002) Antimicrob Agents Chemother 46:1492–1502
Otto M, Echner H, Voelter W, Gotz F (2001) Infect Immun 69:1957–1960
Mayville P, Ji G, Beavis R, Yang H, Goger M, Novick RP, Muir TW (1999) Proc Natl Acad Sci USA 96:1218–1223
Lyon GJ, Wright JS, Muir TW, Novick RP (2002) Biochemistry 41:10095–10104
Jarraud S, Lyon GJ, Figueiredo AM, Gerard L, Vandenesch F, Etienne J, Muir TW, Novick, RP (2000) J Bacteriol 182:6517–6522
McDowell P, Affas Z, Reynolds C, Holden MT, Wood SJ, Saint S, Cockayne A, Hill PJ, Dodd CE, Bycroft BW, Chan WC, Williams P (2001) Mol Microbiol 41:503–512
Goerke C, Kummel M, Dietz K, Wolz C (2003) J Infect Dis 188:250–256
Otto M, Sussmuth R, Vuong C, Jung G, Gotz F (1999) FEBS Lett 450:257–262
van Leeuwen W, van Nieuwenhuizen W, Gijzen C, Verbrugh H, van Belkum A (2000) J Bacteriol 182:5721–5729
Chan WC, Coyle BJ, Williams P (2004) J Med Chem 47:4633–4641
Lyon GJ, Mayville P, Muir TW, Novick RP (2000) Proc Natl Acad Sci USA 97:13330–13335
Zhang L, Ji G (2004) J Bacteriol 186:6706–6713
Wright JS III, Lyon GJ, George EA, Muir TW, Novick RP (2004) Proc Natl Acad Sci USA 101:16168–16173
Qazi S, Middleton B, Muharram SH, Cockayne A, Hill P, O’Shea P, Chhabra SR, Camara M, Williams P (2006) Infect Immun 74:910–919
Huntzinger E, Boisset S, Saveanu C, Benito Y, Geissmann T, Namane A, Lina G, Etienne J, Ehresmann B, Ehresmann C, Jacquier A, Vandenesch F, Romby P (2005) EMBO J 24:824–835
Morfeldt E, Taylor D, von Gabain A, Arvidson S (1995) EMBO J 14:4569–4577
Arvidson S, Tegmark K (2001) Int J Med Microbiol 291:159–170
Benito Y, Kolb FA, Romby P, Lina G, Etienne J, Vandenesch F (2000) RNA 6:668–679
Balaban N, Stoodley P, Fux CA, Wilson S, Costerton JW, Dell’Acqua G (2005) Clin Orthopedic Relat Res 437:48–54
Korem M, Sheoran AS, Gov Y, Tzipori S, Borovok I, Balaban N (2003) FEMS Microbiol Lett 223:167–175
Korem M, Gov Y, Kiran MD, Balaban N (2005) Infect Immun 73:6220–6228
Kullik I, Giachino P (1997) Arch Microbiol 167:151–159
Bischoff M, Entenza JM, Giachino P (2001) J Bacteriol 183:5171–5179
Otto M (2004) FEMS Microbiol Lett 241:135–141
Vuong C, Saenz HL, Gotz F, Otto M (2000) J Infect Dis 182:1688–1693
Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M (2003) J Infect Dis 188:706–718
Vuong C, Kocianova S, Yao Y, Carmody AB, Otto M (2004) J Infect Dis 190:1498–1505
Schwan WR, Langhorne MH, Ritchie HD, Stover CK (2003) FEMS Immunol Med Microbiol 38:23–28
Kahl BC, Belling G, Becker P, Chatterjee I, Wardecki K, Hilgert K, Cheung AL, Peters G, Herrmann M (2005) Infect Immun 73:4119–4126
Kong KF, Vuong C, Otto M (2006) Int J Med Microbiol 296:133–139
Yarwood JM, Bartels DJ, Volper EM, Greenberg EP (2004) J Bacteriol 186:1838–1850
Xiong YQ, van Wamel W, Nast CC, Yeaman MR, Cheung AL, Bayer AS (2002) J Infect Dis 186:668–677
Goerke C, Campana S, Bayer MG, Doring G, Botzenhart K, Wolz C (2000) Infect Immun 68:1304–1311
Sakoulas G, Eliopoulos GM, Fowler VG Jr, Moellering RC Jr, Novick RP, Lucindo N, Yeaman MR, Bayer AS (2005) Antimicrob Agents Chemother 49:2687–2692
Balaban N, Giacometti A, Cirioni O, Gov Y, Ghiselli R, Mocchegiani F, Viticchi C, Del Prete MS, Saba V, Scalise G, Dell’Acqua G (2003) J Infect Dis 187:625–630
Cirioni O, Giacometti A, Ghiselli R, Dell’Acqua G, Orlando F, Mocchegiani F, Silvestri C, Licci A, Saba V, Scalise G, Balaban N (2006) J Infect Dis 193:180–186
Dell’Acqua G, Giacometti A, Cirioni O, Ghiselli R, Saba V, Scalise G, Gov Y, Balaban N (2004) J Infect Dis 190:318–320
Giacometti A, Cirioni O, Ghiselli R, Dell’Acqua G, Orlando F, D’Amato G, Mocchegiani F, Silvestri C, Del Prete MS, Rocchi M, Balaban N, Saba V, Scalise G (2005) Peptides 26:169–175
Giacometti A, Cirioni O, Gov Y, Ghiselli R, Del Prete MS, Mocchegiani F, Saba V, Orlando F, Scalise G, Balaban N, Dell’Acqua G (2003) Antimicrob Agents Chemother 47:1979–1983
Miller MB, Bassler BL (2001) Annu Rev Microbiol 55:165–199
Winans SC, Bassler BL (2002) J Bacteriol 184:873–883
Surette MG, Miller MB, Bassler BL (1999) Proc Natl Acad Sci USA 96:1639–1644
Xavier KB, Bassler BL (2003) Curr Opin Microbiol 6:191–197
Blevins JS, Revel AT, Caimano MJ, Yang XF, Richardson JA, Hagman KE, Norgard MV (2004) Infect Immun 72:4864–4867
Winzer K, Hardie KR, Burgess N, Doherty N, Kirke D, Holden MT, Linforth R, Cornell KA, Taylor AJ, Hill PJ, Williams P (2002) Microbiology 148:909–922
Cole SP, Harwood J, Lee R, She R, Guiney DG (2004) J Bacteriol 186:3124–3132
McNab R, Ford SK, El Sabaeny A, Barbieri B, Cook GS, Lamont RJ (2003) J Bacteriol 185:274–284
Merritt J, Qi F, Goodman SD, Anderson MH, Shi W (2003) Infect Immun 71:1972–1979
Xu L, Li H, Vuong C, Vadyvaloo V, Wang J, Yao Y, Otto M, Gao Q (2006) Infect Immun 74:488–496
Doherty N, Holden MT, Qazi SN, Williams P, Winzer K (2006) J Bacteriol 188:2885–2897
Valle J, Toledo-Arana A, Berasain C, Ghigo JM, Amorena B, Penades JR, Lasa I (2003) Mol Microbiol 48:1075–1087
Kaufmann GF, Sartorio R, Lee SH, Rogers CJ, Meijler MM, Moss JA, Clapham B, Brogan AP, Dickerson TJ, Janda KD (2005) Proc Natl Acad Sci USA 102:309–314
Yang G, Gao Y, Dong J, Xue Y, Fan M, Shen B, Liu C, Shao N (2006) Vaccine 24:1117–1123
Yang G, Cheng H, Liu C, Xue Y, Gao Y, Liu N, Gao B, Wang D, Li S, Shen B, Shao N (2003) Peptides 24:1823–1828
Yang G, Gao Y, Dong J, Liu C, Xue Y, Fan M, Shen B, Shao N (2005) J Biol Chem 280:27431–27435
Acknowledgements
The work in our laboratory is funded by the Deutsche Forschungsgemeinschaft (He 1850/5–2) and the University of Saarland Medical Faculty (HOMFOR).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Harraghy, N., Kerdudou, S. & Herrmann, M. Quorum-sensing systems in staphylococci as therapeutic targets. Anal Bioanal Chem 387, 437–444 (2007). https://doi.org/10.1007/s00216-006-0860-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-006-0860-0